These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8201343)

  • 1. Idiopathic AA amyloidosis manifested by autonomic neuropathy, vestibulocochleopathy, and lattice corneal dystrophy.
    Tsunoda I; Awano H; Kayama H; Tsukamoto T; Ueno S; Fujiwara T; Watanabe M; Yamamoto T
    J Neurol Neurosurg Psychiatry; 1994 May; 57(5):635-7. PubMed ID: 8201343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy.
    Darras BT; Adelman LS; Mora JS; Bodziner RA; Munsat TL
    Neurology; 1986 Mar; 36(3):432-5. PubMed ID: 3513049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of evidence for protein AA reactivity in amyloid deposits of lattice corneal dystrophy and amyloid corneal degeneration.
    Gorevic PD; Rodrigues MM; Krachmer JH; Green C; Fujihara S; Glenner GG
    Am J Ophthalmol; 1984 Aug; 98(2):216-24. PubMed ID: 6383050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid fibril protein in familial amyloidosis with cranial neuropathy and corneal lattice dystrophy (FAP type IV) is related to transthyretin.
    Maury CP; Teppo AM; Karinemi AL; Koeppen AH
    Am J Clin Pathol; 1988 Mar; 89(3):359-64. PubMed ID: 3258117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lattice corneal dystrophy type II associated with familial amyloid polyneuropathy type IV.
    Akiya S; Nishio Y; Ibi K; Uozumi H; Takahashi H; Hamada T; Onishi A; Ishiguchi H; Hoshii Y; Nakazato M
    Ophthalmology; 1996 Jul; 103(7):1106-10. PubMed ID: 8684801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive cranial nerve involvement and grading of facial paralysis in gelsolin amyloidosis.
    Pihlamaa T; Salmi T; Suominen S; Kiuru-Enari S
    Muscle Nerve; 2016 May; 53(5):762-9. PubMed ID: 26422119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy.
    Boysen G; Galassi G; Kamieniecka Z; Schlaeger J; Trojaborg W
    J Neurol Neurosurg Psychiatry; 1979 Nov; 42(11):1020-30. PubMed ID: 228009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Familial amyloid polyneuropathy type IV (Finnish type)--a clinicopathological study].
    Makishita H; Yazaki M; Matsuda M; Ikeda S; Yanagisawa N
    Rinsho Shinkeigaku; 1994 May; 34(5):431-7. PubMed ID: 7924053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Sporadic" prealbumin-related amyloid polyneuropathy: report of two cases.
    Yamada M; Tsukagoshi H; Satoh J; Ishiai S; Nakazato M; Furuya H; Sasaki H; Sakaki Y; Yokota T
    J Neurol; 1987 Dec; 235(2):69-73. PubMed ID: 2828557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial amyloidosis of the Finnish type (FAF). A clinical study of 30 patients.
    Kiuru S
    Acta Neurol Scand; 1992 Oct; 86(4):346-53. PubMed ID: 1333716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunohistochemical study of gelsolin immunoreactivity in corneal amyloidosis.
    Loeffler KU; Edward DP; Tso MO
    Am J Ophthalmol; 1992 May; 113(5):546-54. PubMed ID: 1315488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonfamilial prealbumin-type amyloid polyneuropathy.
    Ochiai J; Tobimatsu S; Kobayashi T; Kitamoto T; Kitaguchi T; Furuya H; Goto I; Kuroiwa Y
    Arch Neurol; 1986 Dec; 43(12):1294-5. PubMed ID: 3022697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lattice corneal dystrophy type II with familial amyloid polyneuropathy type IV].
    Asaoka T; Amano S; Sunada Y; Sawa M
    Nippon Ganka Gakkai Zasshi; 1993 Nov; 97(11):1332-6. PubMed ID: 8285156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal morphology and sensitivity in lattice dystrophy type II (familial amyloidosis, Finnish type).
    Rosenberg ME; Tervo TM; Gallar J; Acosta MC; Müller LJ; Moilanen JA; Tarkkanen AH; Vesaluoma MH
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):634-41. PubMed ID: 11222521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lattice corneal dystrophy type III with corneal fistula. A case report.
    Sridhar MS; Sridhar U; Vemuganti GK; Mandal AK
    Indian J Ophthalmol; 2004 Sep; 52(3):236-8. PubMed ID: 15510466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lattice corneal dystrophy associated with familial systemic amyloidosis (Meretoja's syndrome).
    Purcell JJ; Rodrigues M; Chishti MI; Riner RN; Dooley JM
    Ophthalmology; 1983 Dec; 90(12):1512-7. PubMed ID: 6610849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Climatic droplet keratopathy with corneal amyloidosis.
    Matta CS; Tabbara KF; Cameron JA; Hidayat AA; al-Rajhi AA
    Ophthalmology; 1991 Feb; 98(2):192-5. PubMed ID: 2008277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lattice corneal dystrophy type II with familial amyloid polyneuropathy type IV.
    Asaoka T; Amano S; Sunada Y; Sawa M
    Jpn J Ophthalmol; 1993; 37(4):426-31. PubMed ID: 8145387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy.
    Mathis S; Magy L; Diallo L; Boukhris S; Vallat JM
    Muscle Nerve; 2012 Jan; 45(1):26-31. PubMed ID: 22190302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy.
    Rajkumar SV; Gertz MA; Kyle RA
    Am J Med; 1998 Mar; 104(3):232-7. PubMed ID: 9552085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.